Title of cohort

    The Vallecas Project

    Acronym for cohort

    Name of Principal Investigator - Title

    Dr

    Name of Principal Investigator - First name

    Miguel

    Name of Principal Investigator - Last name

    Medina Padilla

    Address of institution -Institution

    CIEN Foundation

    Address of institution - Street address

    C/ Valderrebollo, 5

    Address of institution - City

    Madrid

    Address of institution - Postcode

    28031

    Country

    Spain

    Contact email
    Funding source

    info@fundacioncien.es

    Q1a. Please indicate below if your cohort includes or expects to include, incidence of the following conditions?

    Alzheimer's disease and other dementias

    Q1b. When are studies on the above condition(s) expected to become possible?

    Already possible

    Q2a. In a single sentence what is the stated aim of the cohort?

    Identify various markers to eventually determine the potential risk that each individual could have to develop the disease in the future and determine an early detection of Alzheimer's Disease

    Q2b. What distinguishes this cohort from other population cohorts?

    Q3a. i) Number of publications that involve use of your cohort to date

    Q3a.ii) Please give up to three examples of studies to date (Principal Investigator, Institution, Title of Study)

    Q3b. If data on research outputs are already available please paste the publication list/other data or provide a link to where these data are publicly available

    Q3c. If no research has been done as yet, please explain in a few sentences what information (i.e. research findings) you expect will be gained from the population

    Q4a. Study criteria: what is the age range of participants at recruitment? Age in years From:

    70

    Q4a. Study criteria: what is the age range of participants at recruitment? To:

    85

    Q4b. Study criteria: what are the inclusion criteria?

    Signing an informed consent; be aged between 70 and 85 years old; availability and ability to reach the Alzheimer Centre for visits; and visual and hearing abilities that allow conducting the study tests.

    Q4c. Study criteria: what are the exclusion criteria?

    Suspected or diagnosed dementia; inability to perform neuroimaging studies; alcohol abuse; mental retardation; or history of certain psychiatric or neurological diseases

    Q5. What is the size of the cohort (i.e. how many participants have enrolled)?

    1,000-5,000 participants

    Q6a. Please describe what measures are used to characterise participants

    Sociodemographic, Clinical, Neuroimaging, Neurological and Neuropsychological measures

    Q6b. Are there additional measures for participants with a clinical disorder?

    Q6c. Are there defined primary and secondary endpoints (e.g. defined health parameters)?

    No

    If yes please specify

    Q7. What is the study design (select all that apply)?

    Prospective cohort|Longitudinal

    Q8. Are your cases matched by

    Age

    Q9a. Does your study include a specialised subset of control participants?

    Yes

    Q9b. If your study includes a specialised subset of control participants please describe

    Q10a. i) Please enter the data collection start date

    01/01/2011

    Q10a. ii) Please enter the data collection end date

    Q10a. iii) Is data collection for this study

    Data collection ongoing| Data analysis ongoing

    Q10b. If data collection is ongoing, are there plans to continue the cohort study beyond the current projected end date?

    Q11. Is data collected

    Other please specify here

    Q12. Is there a system in place to enable re-contact with patients to ask about participation in future studies?

    Yes (participants given permission to be re-contacted via PIs)

    Q13a. Please give information on the format and availability of data stored in a database (1)

    % available

    Q13a. Please give information on the format and availability of data stored in a database (2)

    Database is web-based

    % available

    Q13a. Please give information on the format and availability of data stored in a database (3)

    Database on spreadsheet (e.g. excel)

    % available

    Q13a. Please give information on the format and availability of data stored in a database (4)

    % available

    Other (please specify)

    % available

    Q13b. Please give information on the format and availability of data held as individual records (1)

    % available

    Q13b. Please give information on the format and availability of data held as individual records (2)

    % available

    Q13b. Please give information on the format and availability of data held as individual records (3)

    Data held on computer based records

    % available

    Q13b. Please give information on the format and availability of data held as individual records (4)

    % available

    Please specify language used

    Q14a. Is data available to other groups?

    No

    Q14b. If data is available to other groups what is the access policy/mechanisms for access?

    Q15. What data sharing policy is specified as a condition of use?

    No policy exists

    Q16a. Are tissues/samples/DNA available to other groups?

    Yes

    Q16b i) If yes, please describe below:

    Living donors: blood| Living donors: blood derivatives| Living donors: DNA| Post-mortem donors: brain

    Q16b. ii) In what form are tissues/samples/DNA supplied?

    Primary samples: Supplied fresh| Primary Samples: Stabilised samples (frozen or fixed)| Secondary samples:(derivatives of primary samples)| Secondary samples: plasma| Secondary samples: DNA| Secondary samples: RNA| Secondary samples: protein extracts| Secondary samples: cell lines derived from primary samples

    Q16b. iii) Is the access policy/mechanism for obtaining samples the same as that for obtaining data (Q14 above)?

    No

    Q17. Is information on biological characteristics available to other groups?

    No

    Number of Patients

    % of total cohort

Types: Population Cohorts
Member States: Spain
Diseases: Alzheimer's disease & other dementias
Years: 2016
Database Categories: N/A
Database Tags: N/A

Export as PDF